Ubs Group Ag Codex Dna, Inc. Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	42,471 Added 14544.86%	42,763 $79,000
Q3 2023 Nov 09, 2023	BUY	N/A	20 Added 7.35%	292 $0
Q1 2023 May 12, 2023	SELL	$1.3 - $2.15 $4,516 - $7,469	-3,474 Reduced 92.74%	272 $0
Q4 2022 Feb 08, 2023	BUY	$1.12 - $1.69 $4,148 - $6,259	3,704 Added 8819.05%	3,746 $4,000
Q3 2022 Nov 10, 2022	SELL	$1.7 - $2.36 $10,424 - $14,471	-6,132 Reduced 99.32%	42 $0
Q2 2022 Aug 10, 2022	BUY	$1.8 - $6.45 $11,113 - $39,822	6,174 New	6,174 $11,000
Q1 2022 May 16, 2022	SELL	$4.12 - $10.36 $11,647 - $29,287	-2,827 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $17,838 - $33,810	2,827 New	2,827 $31,000
Q3 2021 Nov 15, 2021	SELL	$10.15 - $19.88 $6,323 - $12,385	-623 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $11,064 - $13,706	623 New	623 $14,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.